Inventor · disambiguated record
Olivier Crespin
Also filed as: CRESPIN OLIVIER
9 granted patents·2 pending applications·31 citations·filing 1997–2013
82Inventor score
Technology areasA61P
Top patents by PatentIndex Score
11 records- 0182US7947834B2Substituted quinoxalines, their preparation and their therapeutical use as 11βHSD1 modulatorsSANOFI AVENTIS·Filed 2008·Granted May 24, 2011·8 cites·13 claims
- 0269US7569582B2Aminotropane derivatives, preparation thereof and therapeutic use thereofSANOFI AVENTIS·Filed 2007·Granted Aug 4, 2009·2 cites·15 claims
- 0364US8211892B2Tetrahydroquinoxaline urea derivativesBRAUN ALAIN JEAN·Filed 2010·Granted Jul 3, 2012·1 cites·24 claims
- 0460US6200991B1Imidazole derivatives, preparation and therapeutic application thereofSANOFI SYNTHELABO·Filed 1998·Granted Mar 13, 2001·17 cites·16 claims
- 0550US8530477B2Tropane urea derivatives, preparation thereof and therapeutic application thereof as modulators of the activity of 11betaHSD1BRAUN ALAIN JEAN·Filed 2009·Granted Sep 10, 2013·0 cites·9 claims
- 0645US8530657B2Substituted adamantanes and their therapeutic applicationBRAUN ALAIN JEAN·Filed 2012·Granted Sep 10, 2013·0 cites·1 claims
- 0742US2007149562A1Oxopiperidine derivatives, preparation and therapeutic use thereofSANOFI AVENTIS·Filed 2007·Application pending·0 cites
- 0840US9120812B2Pyrimidooxazocine derivatives as mTOR-inhibitorsSANOFI SA·Filed 2013·Granted Sep 1, 2015·0 cites·13 claims
- 0940US2007191364A1Aminopiperidine derivatives, preparation thereof and therapeutic use thereofSANOFI AVENTIS·Filed 2007·Application pending·0 cites
- 1036US6060508ABenzylamine derivatives, their preparation and their application in therapeuticsSYNTHELABO·Filed 1997·Granted May 9, 2000·3 cites·23 claims
- 1128US8536173B2Tetrahydroquinoxaline urea derivatives as modulators of 11-B-hydroxysteroid dehydrogenase type ICRESPIN OLIVIER·Filed 2010·Granted Sep 17, 2013·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when Olivier Crespin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →